FDA Adverse Event Injury Summary report: N

GYNECARE TVT RETROPUBIC SYSTEM

MDR report key: 3214080 · Received July 9, 2013

Report

Report Number
2210968-2013-12680
Event Type
Injury
Date Received
July 9, 2013
Report Date
November 23, 2017
Manufacturer
ETHICON INC.
Product Code
OTN
PMA / PMN Number
K974098
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

IT WAS REPORTED THAT FOLLOWING INSERTION PATIENT EXPERIENCED MIXED INCONTINENCE AND CYSTOCELE. IT WAS REPORTED THAT PATIENT UNDERWENT RIGID CYSTOURETHROSCOPY ON (B)(6) 2013 BY DR. (B)(6) HOSPITAL.

Additional Manufacturer Narrative · 1

(B)(4). NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL SURGICAL PROCEDURE AND A MESH WAS IMPLANTED CONCURRENTLY WITH LAPAROTOMY, TAH/LSO, POSTERIOR REPAIR, AND CYSTOSCOPY. NO ADDITIONAL INFORMATION WAS PROVIDED.

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2003 AND MESH WAS IMPLANTED CONCURRENTLY WITH TOTAL ABDOMINAL HYSTERECTOMY, LEFT SALPINGO-OOPHORECTOMY, CYSTOSCOPY, DUE TO IRREGULAR UTERINE BLEEDING, OVARIAN CYSTS, STRESS URINARY INCONTINENCE, CYSTOCELE/RECTOCELE, AND HYPERMOBILE URETHRA. THE PATIENT EXPERIENCED PAIN, EROSION OF INTERNAL TISSUES, AND HAS UNDERGONE ADDITIONAL SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION IS PROVIDED AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
312656 GYNECARE TVT RETROPUBIC SYSTEM MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC OTN ETHICON INC. UNK 1060687

Patients

Seq Age Sex Outcome Treatment
1 43 YR Required Intervention